公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement | SUNG-HSIN KUO ; ANN-LII CHENG ; CHUNG-WU LIN ; CHIH-HUNG HSU ; MING-SHIANG WU ; KUN-HUEI YEH ; Tzeng Y.-S.; Chen L.-T. | Cancer Chemotherapy and Pharmacology | 13 | 8 | |
1995 | Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells | YEONG-SHIAU PU ; Hsieh T.-S.; Tsai T.-C.; ANN-LII CHENG ; CHANG-YAO HSIEH ; Su I.-J.; Lai M.-K. | The Journal of Urology | 35 | 30 | |
2013 | Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma | YU-CHIEH TSAI ; Yeh C.-H.; KAI-YUAN TZEN ; Ho P.-Y.; Tuan T.-F.; YEONG-SHIAU PU ; ANN-LII CHENG ; CHIA-HSIEN CHENG | European Journal of Cancer | 26 | 24 | |
2012 | Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma | ANN-LII CHENG ; Ying-Chun Shen ; Zhu A.X. | Oncology | 39 | 41 | |
2018 | Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice | CHIAO-LING TSAI ; Liu W.-L.; Feng-Ming Hsu ; Yang P.-S.; RUOH-FANG YEN ; KAI-YUAN TZEN ; ANN-LII CHENG ; PEI-JER CHEN ; CHIA-HSIEN CHENG | Hepatology | 26 | 26 | |
2014 | Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma | Liu W.-L.; Gao M.; KAI-YUAN TZEN ; CHIAO-LING TSAI ; Feng-Ming Hsu ; ANN-LII CHENG ; CHIA-HSIEN CHENG | Oncotarget | 38 | 39 | |
2018 | Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma | Chang C.-J.; YAO-HSU YANG ; Chiu C.-J.; LI-CHUN LU ; Liao C.-C.; Liang C.-W.; CHIH-HUNG HSU ; ANN-LII CHENG | International Journal of Cancer | 42 | 37 | |
1997 | Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene | Chuang S.-E.; SHIN-LIAN DOONG ; Lin M.-T.; ANN-LII CHENG | Biochemical and Biophysical Research Communications | 8 | 10 | |
1997 | Thymic carcinoma with autoimmune syndrome: Successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin | CHIH-HUNG HSU ; KUN-HUEI YEH ; ANN-LII CHENG | Anticancer Research | 18 | 17 | |
2023 | Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial | Ren, Zhenggang; Ducreux, Michel; Abou-Alfa, Ghassan K; Merle, Philippe; Fang, Weijia; Edeline, Julien; Li, Zhiwei; Wu, Lihua; Assenat, Eric; Hu, Sheng; Rimassa, Lorenza; Zhang, Tao; Blanc, Jean-Frédéric; Pan, Hongming; Ross, Paul; Yen, Chia-Jui; Tran, Albert; Shao, Guoliang; Bouattour, Mohamed; Chen, Yajin; Meyer, Tim; Hou, Jinlin; Tougeron, David; Bai, Yuxian; Hou, Ming-Mo; Meng, Zhiqiang; Wu, John; Li, Vincent; Chica-Duque, Sandra; ANN-LII CHENG | Liver cancer | 10 | 10 | |
2005 | Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: Tissue accumulation and the reversibility after washout are tissue-selective | CHUN-JUNG LIN ; MEI-HWAN WU ; Hsueh Y.-M.; Sun S.S.-M.; ANN-LII CHENG | Cancer Chemotherapy and Pharmacology | 23 | 18 | |
2023 | Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity | CHIAO-LING TSAI ; Yang, Po-Sheng; FENG-MING HSU ; ANN-LII CHENG ; Yu, Wan-Ni; CHIA-HSIEN CHENG | Journal of clinical and translational hepatology | 2 | 1 | |
2015 | TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays | CHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG | Scientific Reports | 10 | 11 | |
1998 | Transactivation of the human MDR1 gene by hepatitis B virus X gene product | SHIN-LIAN DOONG ; Lin M.-H.; Tsai M.-M.; Li T.-R.; Chuang S.-E.; ANN-LII CHENG | Journal of Hepatology | 12 | 11 | |
2023 | Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma | HUANG-CHUN LIEN ; Hsu, Chia-Lang; YEN-SHEN LU ; WEI-WU CHEN ; I-CHUN CHEN ; Li, Yu-Chia; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN | Breast cancer research : BCR | 0 | 0 | |
1997 | Transforming growth factor β1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells | Kuo M.-L.; Chen C.-W.; SHIOU-HWA JEE ; Chuang S.-E.; ANN-LII CHENG | Biochemical Journal | 18 | 19 | |
2010 | Translocation of Helicobacter pylori CagA into human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma | Lin W.-C.; Tsai H.-F.; SUNG-HSIN KUO ; MING-SHIANG WU ; CHUNG-WU LIN ; Hsu P.-I.; ANN-LII CHENG ; PING-NING HSU | Cancer Research | 79 | 69 | |
2015 | Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials | YU-YUN SHAO ; Shau, W.-Y.; Chan, S.-Y.; LI-CHUN LU ; CHIH-HUNG HSU ; ANN-LII CHENG | Oncology (Switzerland) | 29 | 29 | |
2000 | Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel | CHIH-HUNG HSU ; Chen M.-Y.; ANN-LII CHENG | Anticancer Research | 6 | 4 | |
2017 | Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma | WEN-CHI YANG ; CHUN-WEI WANG ; RUEY-LONG HONG ; CHIAO-LING TSAI ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; ANN-LII CHENG ; SUNG-HSIN KUO | Journal of Radiation Research | 9 | 9 | |